Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.42
+0.69 (2.17%)
At close: Nov 10, 2026, 4:00 PM EST
32.38
-0.04 (-0.12%)
After-hours: Nov 10, 2026, 4:10 PM EST

Immunocore Holdings Revenue

In the year 2025, Immunocore Holdings had annual revenue of $400.02M with 28.95% growth. That makes Immunocore Holdings the 12,182nd largest company in the world by revenue and 2,390th in the United States.

Revenue (ttm)
$400.02M
Revenue Growth
+28.95%
P/S Ratio
3.90
Revenue / Employee
$819,282
Employees
524
Market Cap
1.68B

Revenue Chart

Revenue by Geography

  • United States 257.00M 64.2%
  • Europe 131.42M 32.9%
  • International 11.60M 2.9%
Fiscal year ended Dec 31, 2025 See the full Immunocore Holdings breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025400.02M89.81M28.95%
Dec 31, 2024310.20M60.77M24.37%
Dec 31, 2023249.43M75.53M43.44%
Dec 31, 2022173.89M138.04M384.99%
Dec 31, 202135.85M-5.32M-12.91%
Dec 31, 202041.17M7.13M20.95%
Dec 31, 201934.04M3.91M12.98%
Dec 31, 201830.13M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.